| CID 77108121 | IC50 | 1.0 [1] |
| CID 77108121 | Ki | 0.98 [1] |
| 5-Benzyl-N-[(3S)-4-oxo-3,5-dihydro-2H-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 16.0 [1], 200.0 [2] |
| 5-Benzyl-N-[(3s)-5-Methyl-4-Oxo-2,3,4,5-Tetrahydro-1,5-Benzoxazepin-3-Yl]-1,2-Oxazole-3-Carboxamide | IC50 | 1.6 [1], 2.8 [2], 10.0 [3] |
| 5-Benzyl-N-[(3s)-5-Methyl-4-Oxo-2,3,4,5-Tetrahydro-1,5-Benzoxazepin-3-Yl]-1,2-Oxazole-3-Carboxamide | Ki | 0.8 [1] |
| 1-[4-(1-Aminoisoquinolin-5-Yl)phenyl]-3-(5-Tert-Butyl-1,2-Oxazol-3-Yl)urea | IC50 | 10.0 [1], 16.0 [2], 25.0 [3], 500.0 [4], 630.0 [5] |
| 3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-[2-fluoro-5-(trifluoromethyl)phenyl]urea | IC50 | 13.0 [1], 63.0 [2], 250.0 [3] |
| 3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-[2-fluoro-5-(trifluoromethyl)phenyl]urea | Ki | 2.04 [1] |
| 5-Benzyl-N-[(3R)-4-oxo-3,5-dihydro-2H-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 10000.0 [1] |
| CID 76332060 | IC50 | 1.3 [1], 16.0 [2], 32.0 [3] |
| (5r)-5-[(7-Chloro-1h-Indol-3-Yl)methyl]-3-Methylimidazolidine-2,4-Dione | IC50 | 200.0 [1], 320.0 [2], 630.0 [3] |
| 3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-[3,5-bis(trifluoromethyl)phenyl]urea | IC50 | 32.0 [1], 320.0 [2], 7900.0 [3] |
| 3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-[3-(trifluoromethyl)phenyl]urea | IC50 | 10.0 [1], 20.0 [2], 1000.0 [3] |
| 5-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1H-1,5-benzodiazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 0.79 [1], 40.0 [2] |
| 5-Benzyl-N-[(3S)-1-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 0.2 [1], 6.3 [2] |
| 3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-[2-chloro-5-(trifluoromethyl)phenyl]urea | IC50 | 2500.0 [1], 10000.0 [2] |
| 1-Phenyl-3-[3-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]urea | IC50 | 400.0 [1], 600.0 [2], 1300.0 [3] |
| 5-Benzyl-N-[(3R)-5-methyl-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 0.06 [1], 0.94 [2], 2.0 [3] |
| 1-[4-(4-Aminofuro[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-chlorophenyl)urea | IC50 | 160.0 [1], 200.0 [2], 7900.0 [3] |
| N-[(3S)-4-Oxo-3,5-dihydro-2H-1,5-benzoxazepin-3-yl]-3-phenoxybenzamide | IC50 | 7.9 [1], 40.0 [2], 400.0 [3] |
| 1-[4-(1-Aminoisoquinolin-5-yl)phenyl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea | IC50 | 13.0 [1], 130.0 [2], 630.0 [3] |
| 1-[4-(1-Aminoisoquinolin-5-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea | IC50 | 20.0 [1], 25.0 [2], 630.0 [3] |
| 1-(3-Nitrophenyl)-3-[3-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]urea | IC50 | 16.0 [1], 320.0 [2] |
| 1-[3-(5-Phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]-3-[3-(trifluoromethyl)phenyl]urea | IC50 | 32.0 [1], 79.0 [2] |
| 1-[3-[5-(4-Ethylsulfonylphenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]phenyl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea | IC50 | 3.2 [1], 10.0 [2], 25.0 [3] |
| 1-[2-Fluoro-5-(trifluoromethyl)phenyl]-3-[3-(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]urea | IC50 | 4.0 [1], 6.3 [2], 7.9 [3] |
| 1-[4-(4-Aminofuro[2,3-d]pyrimidin-5-yl)phenyl]-3-[4-fluoro-3-(trifluoromethyl)phenyl]urea | IC50 | 160.0 [1], 500.0 [2], 1300.0 [3] |
| 3-[3-[3-[[2-Fluoro-5-(trifluoromethyl)phenyl]carbamoylamino]phenyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]benzamide | IC50 | 10.0 [1], 16.0 [2], 63.0 [3] |
| 1-[4-(4-Aminofuro[2,3-d]pyrimidin-5-yl)phenyl]-3-[2-fluoro-3-(trifluoromethyl)phenyl]urea | IC50 | 200.0 [1], 250.0 [2], 10000.0 [3] |
| 1-[4-(1-Aminoisoquinolin-5-yl)phenyl]-3-[4-chloro-3-(trifluoromethyl)phenyl]urea | IC50 | 40.0 [1], 160.0 [2], 2000.0 [3] |
| 1-(3-Acetylphenyl)-3-[3-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]urea | IC50 | 10.0 [1], 13.0 [2], 320.0 [3] |
| 1-[3-[5-(4-Aminophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]phenyl]-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea | IC50 | 16.0 [1], 32.0 [2], 50.0 [3] |
| 1-[4-(1-Aminoisoquinolin-5-yl)phenyl]-3-[2-fluoro-3-(trifluoromethyl)phenyl]urea | IC50 | 4000.0 [1], 10000.0 [2] |
| 1-Cyclopentyl-3-[3-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]urea | IC50 | 500.0 [1], 2000.0 [2], 7900.0 [3] |
| 1-[4-(4-Aminofuro[2,3-d]pyrimidin-5-yl)phenyl]-3-[3-fluoro-5-(trifluoromethyl)phenyl]urea | IC50 | 63.0 [1], 130.0 [2], 5000.0 [3] |
| 1-[4-(4-Aminofuro[2,3-d]pyrimidin-5-yl)phenyl]-3-[4-chloro-3-(trifluoromethyl)phenyl]urea | IC50 | 32.0 [1], 160.0 [2], 1300.0 [3] |
| 1-[4-(4-Aminofuro[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-ethylphenyl)urea | IC50 | 10.0 [1], 25.0 [2], 250.0 [3] |
| 1-(3-Methylphenyl)-3-[3-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]urea | IC50 | 13.0 [1], 20.0 [2], 160.0 [3] |
| 1-[4-(1-Aminoisoquinolin-5-yl)phenyl]-3-[4-fluoro-3-(trifluoromethyl)phenyl]urea | IC50 | 10.0 [1], 320.0 [2], 2500.0 [3] |
| 1-[2-Fluoro-5-(trifluoromethyl)phenyl]-3-[3-[5-(3-methylsulfonylphenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]phenyl]urea | IC50 | 10.0 [1], 50.0 [2], 63.0 [3] |
| 1-[2-Fluoro-5-(trifluoromethyl)phenyl]-3-[3-[5-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]phenyl]urea | IC50 | 6.0 [1], 16.0 [2], 63.0 [3] |
| 1-[4-(1-Aminoisoquinolin-5-yl)phenyl]-3-[3-fluoro-5-(trifluoromethyl)phenyl]urea | IC50 | 25.0 [1], 160.0 [2], 2500.0 [3] |
| 1-[4-(1-Aminoisoquinolin-5-yl)phenyl]-3-[2-chloro-5-(trifluoromethyl)phenyl]urea | IC50 | 630.0 [1], 3200.0 [2], 10000.0 [3] |
| 1-(3-Methoxyphenyl)-3-[3-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]urea | IC50 | 6.3 [1], 32.0 [2], 400.0 [3] |
| 1-[4-(4-Aminofuro[2,3-d]pyrimidin-5-yl)phenyl]-3-(5-tert-butyl-1,2-oxazol-3-yl)urea | IC50 | 16.0 [1], 32.0 [2], 200.0 [3] |
| 1-[2-Fluoro-5-(trifluoromethyl)phenyl]-3-[3-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]urea | IC50 | 80.0 [1], 160.0 [2], 200.0 [3] |
| 5-(1H-Indol-3-ylmethyl)-3-methyl-2-thioxo-4-Imidazolidinone | IC50 | 182.0 [1], 760.0 [2] |
| 3-(4-{4-Aminofuro[2,3-d]pyrimidin-5-yl}phenyl)-1-naphthalen-2-ylurea | IC50 | 100.0 [1], 790.0 [2] |
| 5-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,3,4-oxadiazole-2-carboxamide | IC50 | 0.79 [1], 7.9 [2] |
| N-[(3S)-5-Methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-(2-methylpropyl)-1,2-oxazole-3-carboxamide | IC50 | 1600.0 [1], 6310.0 [2] |
| 1-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]imidazole-4-carboxamide | IC50 | 0.4 [1], 6.3 [2] |
| N-[(3S)-4-Oxo-3,5-dihydro-2H-1,5-benzoxazepin-3-yl]-5-pentyl-1H-pyrazole-3-carboxamide | IC50 | 320.0 [1], 1600.0 [2] |
| 1-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,2,4-triazole-3-carboxamide | IC50 | 0.63 [1], 1.6 [2] |
| 2-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]tetrazole-5-carboxamide | IC50 | 0.08 [1], 2.5 [2] |
| 1-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]pyrazole-4-carboxamide | IC50 | 63.0 [1], 631.0 [2] |
| 1-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]triazole-4-carboxamide | IC50 | 1.0 [1], 25.0 [2] |
| 5-Benzyl-N-[(3S)-5-methyl-4-oxo-7-(1H-pyrazol-5-yl)-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 1.0 [1], 6.3 [2] |
| 5-Benzyl-N-[(3S)-5-methyl-4-oxo-7-(2-oxo-3H-1,3,4-oxadiazol-5-yl)-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 0.5 [1], 3.2 [2] |
| 2-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,3-oxazole-4-carboxamide | IC50 | 794.0 [1], 2512.0 [2] |
| 5-Benzyl-N-[(4S)-5-oxo-2,3,4,6-tetrahydro-1,6-benzoxazocin-4-yl]-1,2-oxazole-3-carboxamide | IC50 | 200.0 [1], 631.0 [2] |
| 5-Benzyl-N-[(3S)-1,5-dimethyl-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 5.0 [1], 20.0 [2] |
| Methyl N-[(3S)-3-[(5-benzyl-1,2-oxazole-3-carbonyl)amino]-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-7-yl]carbamate | IC50 | 0.32 [1], 10.0 [2] |
| 5-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,3-thiazole-2-carboxamide | IC50 | 631.0 [1], 794.0 [2] |
| 5-Benzyl-N-[(3S)-5-ethyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 3162.0 [1], 7943.0 [2] |
| RIP1 kinase inhibitor 1 | IC50 | 1.3 [1] |
| RIP1 kinase inhibitor 1 | Ki | 0.91 [1] |
| 5-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,3-oxazole-2-carboxamide | IC50 | 0.05 [1], 1.0 [2] |
| 5-Benzyl-N-[(3R)-2,3,4,5-tetrahydro-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 10000.0 [1] |
| 5-Benzyl-N-[(6S)-5-oxo-1,4-oxazepan-6-yl]-1,2-oxazole-3-carboxamide | IC50 | 10000.0 [1] |
| N-[(3S)-5-Methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-pentyl-1,2-oxazole-3-carboxamide | IC50 | 100.0 [1], 126.0 [2] |
| 5-Benzyl-1-methyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]pyrazole-3-carboxamide | IC50 | 0.4 [1], 10.0 [2] |
| 4-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]pyridine-2-carboxamide | IC50 | 2.0 [1], 40.0 [2] |
| 5-(Cyclohexylmethyl)-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 251.0 [1], 501.0 [2] |
| 5-Benzyl-N-[(3S)-5-cyclopropyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 10000.0 [1] |
| 5-Benzyl-N-[(3S)-7-(methanesulfonamido)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 0.63 [1], 13.0 [2] |
| 5-Benzyl-N-(2-oxo-3,4-dihydro-1H-quinolin-3-yl)-1,2-oxazole-3-carboxamide | IC50 | 10000.0 [1] |
| 5-Benzyl-N-[(3S)-3-methyl-4-oxo-2,5-dihydro-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 10000.0 [1] |
| N-[(3S)-5-Methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-(piperidin-1-ylmethyl)-1,2-oxazole-3-carboxamide | IC50 | 10000.0 [1] |
| 5-Benzyl-N-methyl-N-[(3S)-4-oxo-3,5-dihydro-2H-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 10000.0 [1] |
| 2-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-imidazole-5-carboxamide | IC50 | 1259.0 [1], 1995.0 [2] |
| 3-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]benzamide | IC50 | 251.0 [1], 398.0 [2] |
| N-[(3S)-7-Acetamido-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-benzyl-1,2-oxazole-3-carboxamide | IC50 | 0.32 [1], 7.9 [2] |
| 5-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,2,4-oxadiazole-3-carboxamide | IC50 | 0.5 [1], 5.0 [2] |
| Tozasertib | IC50 | 208.0 [1] |
| Necrostatin 2 racemate | IC50 | 754.0 [1] |
| CID 121439991 | IC50 | 13.0 [1] |
| Ripk1-IN-7 | IC50 | 11.0 [1] |
| 5-Benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-pyrazole-3-carboxamide | IC50 | 0.4 [1] |
| 5-Benzyl-N-[(3R)-1,1,4-trioxo-3,5-dihydro-2H-1lambda6,5-benzothiazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 79.0 [1] |
| 5-Benzyl-N-[(3S)-4-oxo-1,2,3,5-tetrahydro-1,5-benzodiazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 3.2 [1] |
| N-[(3S)-5-Methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-5-[[3-[3-(trifluoromethyl)diazirin-3-yl]phenyl]methyl]-1H-pyrazole-3-carboxamide | IC50 | 35.0 [1] |
| 5-Benzyl-N-[(3S)-1-methyl-2-oxo-7-[3-(trifluoromethyl)diazirin-3-yl]-4,5-dihydro-3H-1-benzazepin-3-yl]-1,2-oxazole-3-carboxamide | IC50 | 210.0 [1] |
| (3S)-3-(2-Benzyl-3-chloro-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl)-N,5-dimethyl-4-oxo-2,3-dihydro-1,5-benzoxazepine-8-carboxamide | Ki | 0.91 [1] |
| (3S)-3-[2-[(2-Fluorophenyl)methyl]-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl]-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one | Ki | 1.74 [1] |
| (3S)-3-[2-(Cyclobutylmethyl)-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl]-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one | Ki | 13.8 [1] |
| (3S)-3-(2-Benzyl-4-oxo-6,7-dihydropyrazolo[4,3-c]pyridin-5-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one | Ki | 251.19 [1] |
| (3S)-3-[2-[(2,6-Difluorophenyl)methyl]-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl]-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepine-8-carbonitrile | Ki | 1.78 [1] |
| (3S)-3-(2-Benzyl-3-methyl-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl)-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one | Ki | 2.57 [1] |
| (3S)-3-[2-[(1,1-Dioxothian-4-yl)methyl]-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridin-6-yl]-5-methyl-2,3-dihydro-1,5-benzoxazepin-4-one | Ki | 6918.31 [1] |
| 2-Benzyl-6-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide | Ki | 2.51 [1] |